Lam Research SVP sells 52,190 shares at $138.9 under 10b5-1
Lam Research (LRCX): Insider transaction disclosed.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lam Research (LRCX): Insider transaction disclosed. A Senior Vice President reported an open‑market sale of 52,190 shares of common stock on 10/13/2025 at $138.9 per share (Transaction Code: S). The filing states the trade was effected under a Rule 10b5-1 trading plan adopted on June 11, 2025.
Following the sale, the officer beneficially owns 251,047 shares, held directly. The reported total includes shares subject to unvested restricted stock units. This filing reflects a personal share sale and ownership update by a company officer.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 52,190 | $138.90 | $7.25M |
Footnotes (2)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2025.
- F2. The amount reported includes shares subject to unvested restricted stock units.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did LRCX’s officer report on Form 4?
Was the LRCX trade under a 10b5-1 plan?
Does the reported LRCX ownership include RSUs?
What was the transaction code and nature of the LRCX trade?
What is the reporting person’s relationship to LRCX?
AI-generated analysis. How Rhea-AI works. Not financial advice.